
    
      This study will be: controlled, prospective, randomized and double blind.

      Its main objective will be to evaluate the pre and postoperative Gabapentin efficiency in
      orally doses and long term used of it in order to prevent or decrease persistent
      postoperative pain (PPP) in surgeries with high incidence of it (Pain). Patients will be
      randomly divided in two branches; one of them will take 600 mg of Gabapentin twice a day and
      the other group will take Placebo (twice a day also).

      Both groups of patients will have to take one pill the day before the surgery (300 mg) and
      other pill on the surgery day (300mg). After that, the patients will have to continue this
      treatment during 30 days (two doses per day of Gabapentin or placebo).

      After the surgery and after taking the second pill, it will be evaluated:

      postoperative sharp pain, sickness, vomiting, sedation and adverse effects.

      Patients will be evaluated in the pain treatment office (consulting room) the following
      times:

        1. 30 days after the surgery. (taking drugs suspended)

        2. 3 month after the surgery.

        3. 6 months after the surgery.

        4. 12 months after the surgery

      This monitoring treatment will be done in order to evaluate the presence or absence of
      persistent postoperative pain (PPP).
    
  